Search
for
Sort by
Research 181–210 of 493
- Longitudinal clinical course, treatment outcomes, and relapse patterns in alopecia areata: a prospective cohort study
- Treatment of Alopecia Areata with Oral JAK Inhibitor : Focusing on Clinical Outcomes with Baricitinib
- The Use of 308-nm Excimer Laser Therapy in Alopecia Areata and Primary Cicatricial Alopecia: A Systematic Review
- Immune therapies for alopecia areata: evidence and new perspectives
- AIRE Deficiency Leads to the Development of Alopecia Areata‒Like Lesions in Mice
- New Modalities in the Treatment of Refractory Alopecia Areata
- Alopecia Universalis Treated With Tofacitinib: The Role of JAK/STAT Inhibitors in Hair Regrowth
- Alopecia areata: What’s new in the epidemiology, comorbidities, and pathogenesis?
- Safety and efficacy of tofacitinib in 97 alopecia areata patients
- Which is the ideal JAK inhibitor for alopecia areata – Baricitinib, tofacitinib, ritlecitinib or ifidancitinib - Revisiting the immunomechanisms of the JAK pathway
- Alopecia areata susceptibility variant in MHC region impacts expressions of genes contributing to hair keratinization and is involved in hair loss
- Case report: Sequential therapy with dupilumab and baricitinib for severe alopecia areata with atopic dermatitis in children
- Dietary Habits in Japanese Patients with Alopecia Areata
- Evaluating the Therapeutic Potential of Ritlecitinib for the Treatment of Alopecia Areata
- Janus kinase inhibitors for alopecia areata: A narrative review
- Effectiveness and Safety Profile of Oral Tofacitinib in Alopecia Areata: An Observational Study from a Tertiary Hospital
- Rapidly Progressive Alopecia Universalis after Varicella-Zoster Virus Infection: The role of Immune Dysregulation and Tofacitinib treatment
- Alopecia areata: a review of diagnosis, pathogenesis and the therapeutic landscape
- Tofacitinib (Selective Janus Kinase Inhibitor 1 and 3): A promising therapy for the treatment of alopecia areata: A case report of six patients
- Alopecia Areata in Sub-Saharan Africa: A Scoping Review Protocol on Epidemiology, Clinical Presentation, Burden, Treatment, and Evidence Gaps.
- Genetic Basis of Alopecia Areata
- Immunology of alopecia areata
- IL-12/IL-23 neutralization is ineffective for alopecia areata in mice and humans
- Cancer risk in patients with alopecia areata: a nationwide population‐based matched cohort study
- Correlation between increased total serum IgE levels and clinical features in alopecia areata patients
- Immunopathogenesis and Experimental Models of Alopecia Areata: From Mechanistic Insights to Translational Platforms
- Genetic Insights into Acne, Androgenetic Alopecia, and Alopecia Areata: Implications for Mechanisms and Precision Dermatology
- JAK Inhibitors for Treatment of Alopecia Areata
- A Comprehensive Literature Review of JAK Inhibitors in Treatment of Alopecia Areata
- Clinical Translation of Microbiome Research in Alopecia Areata: A New Perspective?